The head of Russia’s sovereign fund said Tuesday (March 9th) that the fund has entered into agreements with production facilities in Italy, Spain, France, and Germany to manufacture the Sputnik V vaccine, the vaccine against COVID-19.
The fund’s president’s speech came after he signed a commercial agreement with a Swiss pharmaceutical company to produce the vaccine in Italy.